Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer

View ORCID ProfileSimon Heeke, Jonathan Benzaquen, Véronique Hofman, Elodie Long-Mira, Virginie Lespinet, Olivier Bordone, Charles-Hugo Marquette, Hervé Delingette, Marius Ilié, Paul Hofman
doi: https://doi.org/10.1101/2020.03.28.20046102
Simon Heeke
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
2Hospital-related biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Heeke
Jonathan Benzaquen
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
4Pulmonary Department, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Véronique Hofman
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
2Hospital-related biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elodie Long-Mira
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
2Hospital-related biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginie Lespinet
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Bordone
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles-Hugo Marquette
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
4Pulmonary Department, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hervé Delingette
5Epione Project-Team, Inria, Université Côte d’Azur, 2004 route des Lucioles, 06902 Sophia Antipolis, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marius Ilié
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
2Hospital-related biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Hofman
1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000 Nice, France
2Hospital-related biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
3FHU OncoAge, Pasteur Hospital, Université Côte d’Azur, 30 avenue de la voie romaine, 06000, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hofman.p@chu-nice.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Tumor mutational burden (TMB) has been proposed as a novel predictive biomarker for the stratification of patients undergoing immune-checkpoint inhibitor (ICI) treatment in non-small cell lung cancer (NSCLC) patients. The assessment of TMB has recently been established using large targeted sequencing panels and numerous studies are ongoing to harmonize the TMB assessment. However, usually “correlation” has been used to evaluate the association between the respective panels and we hypothesized that correlation might overestimate the comparability especially in lower TMB values, thus limiting the joint analysis of targeted sequencing panels for the assessment of TMB.

Methods Thirty NSCLC samples from patients undergoing ICI treatment were consecutively sequenced using three large targeted sequencing panels: FoundationOne, Oncomine TML and QiaSeq TMB, respectively. TMB values were compared in the whole patient population and in a subset of patients where the TMB assessed by FoundationOne was between 5-25 mutations/Mb. Prediction of durable clinical benefit (DCB; >6 months no progression) was assessed using receiver operator characteristics and optimal cut-off values were calculated using Youden’s J.

Results Correlation between the targeted sequencing panels was strong in the whole patient population between the three panels (R2 > 0.79) but was dramatically reduced in the subset of patients with TMB 5 – 25 mutations/Mb. All panels were able to predict DCB in the TMB high population.

Conclusions Assessment of TMB using the three targeted sequencing panels was possible and predictive of response to ICI treatment but “correlation” was an inappropriate measurement to assess the association between the respective panels.

Competing Interest Statement

Simon Heeke has received honoraria from Qiagen and Boehringer Ingelheim. Marius Ilié has received honoraria from Roche, Merck & co, AstraZeneca, BMS and Boehringer Ingelheim. Paul Hofman has received honoraria from Roche, AstraZeneca, BMS, Novartis, Merck, MSD, Bayer, Qiagen, Thermo Fisher and Biocartis. All other authors have no conflict of interest to declare.

Funding Statement

This work has been partially funded by the Canceropôle PACA, the Ligue Dértemental 06 de Lutte contre le cancer, the Conseil Dértemental 06, and the French government through the LABEX SIGNALIFE program with the reference number ANR-11-LABX-0028-01 and the UCIJEDI program, with the reference number ANR-15-IDEX-01, as well as by the French Association for Cancer Research (ARC) by the Canc’air Genexposomics grant. The funding organizations had no role in the design and conduct of the study.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: This work has been partially funded by the Canceropôle PACA, the Ligue Départemental 06 de Lutte contre le cancer, the Conseil Départemental 06, and the French government through the LABEX SIGNALIFE program with the reference number ANR-11-LABX-0028-01 and the UCIJEDI program, with the reference number ANR-15-IDEX-01, as well as by the French Association for Cancer Research (ARC) by the Canc’air Genexposomics grant. The funding organizations had no role in the design and conduct of the study.

  • Conflicts of Interest: Simon Heeke has received honoraria from Qiagen and Boehringer Ingelheim. Marius Ilié has received honoraria from Roche, Merck & co, AstraZeneca, BMS and Boehringer Ingelheim. Paul Hofman has received honoraria from Roche, AstraZeneca, BMS, Novartis, Merck, MSD, Bayer, Qiagen, Thermo Fisher and Biocartis. All other authors have no conflict of interest to declare.

Data Availability

Data will be made accessible upon justified request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer
Simon Heeke, Jonathan Benzaquen, Véronique Hofman, Elodie Long-Mira, Virginie Lespinet, Olivier Bordone, Charles-Hugo Marquette, Hervé Delingette, Marius Ilié, Paul Hofman
medRxiv 2020.03.28.20046102; doi: https://doi.org/10.1101/2020.03.28.20046102
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer
Simon Heeke, Jonathan Benzaquen, Véronique Hofman, Elodie Long-Mira, Virginie Lespinet, Olivier Bordone, Charles-Hugo Marquette, Hervé Delingette, Marius Ilié, Paul Hofman
medRxiv 2020.03.28.20046102; doi: https://doi.org/10.1101/2020.03.28.20046102

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1105)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9792)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2326)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1566)
  • Health Policy (737)
  • Health Systems and Quality Improvement (607)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11665)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2151)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1184)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2193)
  • Public and Global Health (4680)
  • Radiology and Imaging (784)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (275)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (211)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)